In every cohort, patients with high COL8A1 expression exhibited significantly worse overall survival, unequivocally establishing COL8A1 as a robust and reproducible poor prognostic factor in glioma (Figure 4). The gene discussed is COL8A1; the disease is central nervous system cancer.